Vertex Pharmaceuticals Inc
VRTX· Nasdaq
Released Feb 1, 2021, after the close
10-K filed Feb 11, 2021, 42 days after period end · 0000875320-21-000006
| Metric | Q4 2020 | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $1.63B | $1.41B | $870.11M | $651.63M |
| Net Income | $604.19M | $583.23M | $1.55B | $100.68M |
| EPS Diluted |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| $2.30 |
| $2.23 |
| $5.97 |
| $0.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.